Info@ThinkPinkRocks.org

GSK announced today it has begun shipping FLUARIX QUADRIVALENT (Influenza Vaccine) doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research.

Continued here:
GSK starts shipping FLUARIX QUADRIVALENT (Influenza Vaccine) to US healthcare providers

Scroll to Top